纤维蛋白和纤维蛋白原的降解产物：分子机制及临床意义 - Suppr

Suppr

超能文献

Breakdown products of fibrin and fibrinogen: molecular mechanisms and clinical implications.

作者信息

Gaffney P J

出版信息

J Clin Pathol Suppl (R Coll Pathol). 1980;14:10-7.

PMID:6448869

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1347099/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3ac/1347099/9f51950fa5fd/jclinpath00431-0018-a.jpg

相似文献

Breakdown products of fibrin and fibrinogen: molecular mechanisms and clinical implications.纤维蛋白和纤维蛋白原的降解产物：分子机制及临床意义

J Clin Pathol Suppl (R Coll Pathol). 1980;14:10-7.

Structure of fibrinogen and degradation products of fibrinogen and fibrin.

Br Med Bull. 1977 Sep;33(3):245-51. doi: 10.1093/oxfordjournals.bmb.a071443.

[Diagnostic significance of proteolytic breakdown products of fibrinogen and fibrin].[纤维蛋白原和纤维蛋白的蛋白水解降解产物的诊断意义]

Internist (Berl). 1984 Feb;25(2):93-101.

[The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].[DL和DH降解产物在纤维蛋白原和纤维蛋白纤溶酶水解反应中的作用]

Izv Akad Nauk SSSR Biol. 1991 May-Jun(3):334-42.

Fibrinogen/fibrin degradation products (FDP/fdp). Characterization, anticoagulant activity, and influence on laboratory assays.纤维蛋白原/纤维蛋白降解产物（FDP/fdp）。特性、抗凝活性及对实验室检测的影响。

J Oslo City Hosp. 1977 Jun;27(6):69-80.

Progress in the measurement of circulating fibrinogen derivatives.循环纤维蛋白原衍生物测量的进展

Prog Clin Pathol. 1984;9:15-45.

Markers of fibrinogen derivatives used in clinical investigation.临床研究中使用的纤维蛋白原衍生物标志物。

Semin Thromb Hemost. 1985 Apr;11(2):129-32. doi: 10.1055/s-2007-1004369.

[Influence of end products of plasmin-mediated hydrolysis of fibrinogen and fibrin (EF and Ef fragments) on fibrinogen cross-linking].[纤溶酶介导的纤维蛋白原和纤维蛋白水解终产物（EF和Ef片段）对纤维蛋白原交联的影响]

Izv Akad Nauk Ser Biol. 2002 Sep-Oct(5):522-7.

[Kinetics of fibrin lysis by plasmin: inhibition by fibrin degradation products].[纤溶酶介导的纤维蛋白溶解动力学：纤维蛋白降解产物的抑制作用]

Bioorg Khim. 1996 Dec;22(12):911-5.

A regulatory pathway for fibrinogen biosynthesis involving an indirect feedback loop.

Ann N Y Acad Sci. 1982;389:308-22. doi: 10.1111/j.1749-6632.1982.tb22146.x.

引用本文的文献

COVID-19 in comorbid chronic diseased patients, pregnant and lactating women: pathophysiology, available drug treatment, and the most suitable protocol regimen in each group.合并慢性疾病患者、孕妇和哺乳期妇女中的新型冠状病毒肺炎：病理生理学、可用药物治疗以及每组最合适的方案疗程

Inflammopharmacology. 2025 Aug 12. doi: 10.1007/s10787-025-01829-4.

Atrase A, a P-III class metalloproteinase purified from cobra venom, exhibits potent anticoagulant activity by inhibiting coagulation pathway and activating the fibrinolytic system.阿曲酶A是一种从眼镜蛇毒液中纯化得到的III类金属蛋白酶，它通过抑制凝血途径和激活纤溶系统展现出强大的抗凝活性。

Heliyon. 2024 May 12;10(10):e30969. doi: 10.1016/j.heliyon.2024.e30969. eCollection 2024 May 30.

Prognostic markers in patients with COVID-19 requiring intensive care support.需要重症监护支持的COVID-19患者的预后标志物。

J Taibah Univ Med Sci. 2023 Oct;18(5):1089-1098. doi: 10.1016/j.jtumed.2023.02.013. Epub 2023 Mar 10.

Extended coagulation profile of children with Long Covid: a prospective study.儿童长新冠的扩展凝血谱：一项前瞻性研究。

Sci Rep. 2022 Nov 1;12(1):18392. doi: 10.1038/s41598-022-23168-y.

Hemostatic system and COVID-19 crosstalk: A review of the available evidence.止血系统与新型冠状病毒肺炎的相互作用：现有证据综述

World J Methodol. 2022 Sep 20;12(5):331-349. doi: 10.5662/wjm.v12.i5.331.

Impact of various hematological and biochemical parameters on mortality in coronavirus disease 2019 (COVID-19): A single-center study from North India.多种血液学和生化参数对2019冠状病毒病（COVID-19）死亡率的影响：来自印度北部的一项单中心研究。

Lung India. 2022 May-Jun;39(3):230-233. doi: 10.4103/lungindia.lungindia_480_21.

Hematological abnormalities and comorbidities are associated with COVID-19 severity among hospitalized patients: Experience from Bangladesh.血液学异常和合并症与孟加拉国住院患者 COVID-19 严重程度相关：经验。

PLoS One. 2021 Jul 27;16(7):e0255379. doi: 10.1371/journal.pone.0255379. eCollection 2021.

Effects of snake venom proteases on human fibrinogen chains.蛇毒蛋白酶对人纤维蛋白原链的影响。

Blood Transfus. 2010 Jun;8 Suppl 3(Suppl 3):s120-5. doi: 10.2450/2010.019S.

本文引用的文献

ACTIVATION OF THE FIBRIN STABILIZING FACTOR OF PLASMA BY THROMBIN.凝血酶对血浆纤维蛋白稳定因子的激活作用。

Arch Biochem Biophys. 1964 Apr;105:58-67. doi: 10.1016/0003-9861(64)90235-8.

[The products of degradation of human fibrinogen by plasmin. I. Separation and physicochemical properties].[纤溶酶对人纤维蛋白原的降解产物。I. 分离及理化性质]

Ann Inst Pasteur (Paris). 1961 Mar;100:377-89.

The biological significance of fibrinolysis.纤维蛋白溶解的生物学意义。

Lancet. 1956 Sep 15;271(6942):565-8. doi: 10.1016/s0140-6736(56)92048-7.

The products of the action of thrombin on fibrinogen.凝血酶作用于纤维蛋白原的产物。

Biochim Biophys Acta. 1952 Nov;9(5):578-9. doi: 10.1016/0006-3002(52)90213-8.

A structural aspect of human fibrinogen suggested by its plasmin degradation.

FEBS Lett. 1971 Jun 2;15(1):13-16. doi: 10.1016/0014-5793(71)80067-4.

Effects of fibrinogen degradation products on platelets and coagulation.

Thromb Diath Haemorrh Suppl. 1966;20:215-26.

The identification of isopeptide crosslinks in insoluble fibrin.不溶性纤维蛋白中异肽交联的鉴定

Biochem Biophys Res Commun. 1968 Feb 26;30(4):356-62. doi: 10.1016/0006-291x(68)90750-x.

Subunit structure of human fibrinogen, soluble fibrin, and cross-linked insoluble fibrin.人纤维蛋白原、可溶性纤维蛋白和交联不溶性纤维蛋白的亚基结构。

Proc Natl Acad Sci U S A. 1970 Jul;66(3):738-44. doi: 10.1073/pnas.66.3.738.

The effect of fibrin-stabilizing factor on the subunit structure of human fibrin.纤维蛋白稳定因子对人纤维蛋白亚基结构的影响。

J Clin Invest. 1971 Jul;50(7):1506-13. doi: 10.1172/JCI106636.

Cross-link in fibrin polymerized by factor 13: epsilon-(gamma-glutamyl)lysine.

Science. 1968 May 24;160(3830):892-3. doi: 10.1126/science.160.3830.892.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验